Clinical Trial Detail

NCT ID NCT01748149
Title Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

malignant glioma

Therapies

Vemurafenib

Age Groups: child adult

Additional content available in CKB BOOST